t-pain

does not hurt to call a lawyer, especially because the call is usually free.

Massachusetts DOPH published an in depth report about medical marijuana patients. The findings and information in the report are useful for petitioning new qualifying conditions and educating physicians. Similar to the Minnesota DOH reports. https://www.mass.gov/report/massachusetts-department-of-public-health-marijuana-research REPORT Report Massachusetts Department of Public Health Marijuana Research ORGANIZATION: Department of Public Health DATE PUBLISHED: July 9, 2019 The Marijuana Baseline Health Study (MBHS) A legislative mandate required the Massachusetts Department of Public Health (DPH) to conduct a baseline study to investigate three topics: Patterns of use, methods of consumption, and general perceptions of marijuana Incidents of impaired driving and hospitalization related to marijuana use; and Economic and fiscal impacts for state and local governments This study, referred to as the Marijuana Baseline Health Study (MBHS), was conducted by DPH, under the leadership of the DPH Commissioner, in consultation with the Executive Office of Health and Human Services, the Executive Office for Administration and Finance, and the Executive Office of Public Safety and Security. Downloads Open PDF file, 5.37 MB, forMarijuana Based Health Study Final Report (PDF 5.37 MB) Open DOCX file, 4.29 MB, forMarijuana Based Health Study Final Report (Accessible Version) (DOCX 4.29 MB) Good quotes can be found within the report:

Some in depth reports published by the Minnesota DOH on its medical marijuana patients. These reports have been used when petitioning for new conditions. https://www.health.state.mn.us/people/cannabis/about/omcreport.html Annual Cohort Reports Minnesota Medical Cannabis Program Annual Cohort Reporting System This collection of reports presents information regarding participants’ experience in the program, organized by annual cohorts of initial patient enrollments. The program became operational July 1, 2015, so the annual cohorts are patients who enrolled for the first time between July 1 of one year and June 30 of the subsequent year. The same analysis results are presented for each annual cohort and for the aggregate of all annual cohorts combined. Because some analyses require multiple months of observation time after a patient’s enrollment, results for a given annual cohort are not added to this reporting system until approximately 18 months after the end of the cohort year. Link to Archived Reports Condition-Specific Reports Post-Traumatic Stress Disorder Patients in the Minnesota Medical Cannabis Program Report Comprehensive report on the experiences of the first five months of PTSD enrollees. Chapters include: Patient/Caregiver/Healthcare Practitioner descriptive information, Medical cannabis use patterns, Benefits, and Adverse side effects. Appendices include verbatim comments from patients and healthcare practitioners on benefits and adverse side effects. Intractable Pain Patients in the Minnesota Medical Cannabis Program: Experience of Enrollees During the First Five Months Comprehensive report on the experiences of the first five months of intractable pain enrollees. Chapters include: Patient/Caregiver/Healthcare Practitioner descriptive information including patient's primary cause of intractable pain, Medical cannabis use patterns, Benefits including reduction of pain medication, and Adverse side effects. Appendices include verbatim comments from patients and healthcare practitioners on benefits, adverse side effects, and other clinical observations. https://www.health.state.mn.us/people/cannabis/about/archivereport.html Office of Medical Cannabis Archived Reports Minnesota Medical Cannabis Program: Patient Experiences from the First Program Year Comprehensive report drawing on enrollment information, surveys, and patient self-evaluation data completed prior to each medical cannabis purchase. Chapters include: Patient/Caregiver/Healthcare Practitioner descriptive information, Frequency and duration of medical cannabis purchases, Medical cannabis use patters, Benefits, Adverse side effects, Affordability, and Suggestions for improving the program. Extensive appendices include verbatim comments from patients and healthcare practitioners on benefits, adverse side effects, and suggestions for improving the program. Early Survey Results from the Office of Medical Cannabis - May 2016 This report shares results from surveys of patients who enrolled in the program during its first three months and their certifying health care practitioners. A focus of the survey is a rating by the patient of overall benefit and overall negative impact to them from their participation in the program - and parallel assessments by the patient’s certifying health care practitioner. Respondents were also asked to describe the benefits and the negative impacts. Make sure to spend some time reviewing the appendices, where the respondents’ own words are shared.

you going to grow monster 30ft sativas this year? i hope someone starts a challenge, who can grow the tallest tree....

https://www.mlive.com/news/flint/index.ssf/2018/10/despite_flint_water_crime_accu.html "Wells wins distinguished public health award despite involuntary manslaughter charge" just disgusting news over and over again. https://www.abc12.com/content/news/Special-prosecutor-continuing-Flint-water-cases-despite-possible-replacement-504021251.html Dana getting Schuette's buddy Flood out of the picture with Wayne County Prosecutor Kym Worthy stepping in.

since LARA runs the MMFLA and MRTMA microbusiness licensing, it will probably be similar conditions as the MMFLA licensing.

Only thing you have to watch out for is dose. If you see a large bottle of cbd oil in the store, it can be a lot of filler and only a few hundred mg of CBD. you need something at least 200mg 2-3x day of CBD to even have a therapeutic effect. CBD + THC can take less of because they work in tandem. https://www.ncbi.nlm.nih.gov/pubmed/30402932 There are hundreds of compounds found in the marijuana plant, each contributing differently to the antiepileptic and psychiatric effects. Cannabidiol (CBD) has the most evidence of antiepileptic efficacy and does not have the psychoactive effects of ?9 -tetrahydrocannabinol. CBD does not act via cannabinoid receptors and its antiepileptic mechanism of action is unknown. Despite considerable community interest in the use of CBD for paediatric epilepsy, there has been little evidence for its use apart from anecdotal reports, until the last year. Three randomized, placebo-controlled, double-blind trials in Dravet syndrome and Lennox-Gastaut syndrome found that CBD produced a 38% to 41% median reduction in all seizures compared to 13% to 19% on placebo. Similarly, CBD resulted in a 39% to 46% responder rate (50% convulsive or drop-seizure reduction) compared to 14% to 27% on placebo. CBD was well tolerated; however, sedation, diarrhoea, and decreased appetite were frequent. CBD shows similar efficacy to established antiepileptic drugs. WHAT THIS PAPER ADDS: Cannabidiol (CBD) shows similar efficacy in the severe paediatric epilepsies to other antiepileptic drugs. Careful down-titration of benzodiazepines is essential to minimize sedation with adjunctive CBD.

Hope you find something Codger. Maybe you could try starting an adult legalization club at your local library to educate adults and connect them to each other for the gifting of marijuana (which takes place in private, not at the library). the club would just be for adults to talk, not to smoke/trade etc. LEGALIZATION CLUB

Quickest legal way to make money? Open a hydro grow supply store in an area that needs it. Or in a municipality that has opted out / banned dispensaries. A city that bans dispensaries means more people will grow in those areas.

Visiting qualifying patients are part of the MMMA. Out of state cards are accepted by the MMMA too. Some people do go to Michigan, in winter. possibly for family during Thanksgiving. These people still need medicine. Please be considerate of patients from around the USA.

Came across this tidbit of science, worth repeating. Researchers tested people to see if THC and CBD helped prevent migraines. It did! https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968020/ Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort There are only two prospective trials containing a control group evaluating the use of cannabinoids in the treatment of headache disorders, specifically chronic migraine, cluster headache, and medication overuse headache [56, 62]. The first of these two prospective trials was a randomized, double-blind, active-controlled crossover trial with treatment refractory medication overuse headache (MOH) with daily analgesic intake for at least 5 years and several failed detoxification attempts. Patients completed a course of either Ibuprofen 400 mg or Nabilone 0.5 mg daily for 8 weeks, had a 1 week washout, then a second 8 weeks of the other medication. Results showed that Nabilone 0.5 mg daily, a synthetic cannabinoid, was superior in reducing daily analgesic intake, pain intensity, level of medication dependence, and improved quality of life in these patients [62]. The second prospective trial evaluated the use of cannabinoids as both a prophylaxis and acute treatment for both chronic migraine and chronic cluster headache [56]. Patients were given one of two compounds containing 19% THC or a combination of 0.4% THC + 9% CBD. In phase 1, dose finding observations to determine effective dosing was performed with a group of 48 chronic migraineurs. It was found that doses less than 100 mg produced no benefit, while an oral dose of 200 mg administered during a migraine attack decreased acute pain intensity by 55%, which was the dose used in phase 2. In phase 2, chronic migraine patients were assigned to 3 months prophylaxis treatment with either 25 mg per day of Amitriptyline or THC + CBD 200 mg per day. Chronic cluster headache patients were assigned to 1 month prophylaxis treatment with either Verapamil 480 mg per day or THC + CBD 200 mg per day. For acute pain attacks, additional dosing of THC + CBD 200 mg was allowed in both groups. In the migraine patients, the THC + CBD 200 mg prophylaxis provided a 40.4% improvement versus 40.1% with Amitriptyline. In the cluster headache patients, the THC + CBD 200 mg prophylaxis gave minimal to no benefit. Additional acute THC + CBD 200 mg dosing decreased pain intensity in migraine patients by 43.5%. This same result was seen in cluster headache patients, but only if they had a history of migraine in childhood. In cluster headache patients without a previous history of childhood migraine, the additional THC-CBD 200 mg abortive treatment provided no benefit as an acute treatment.

No, Michigan does not restrict products to low THC, if you have an out of state med card. You may want to call ahead to a specific dispensary to ask if they accept out of state/Georgia cards. I would say they should, but its kind of a strange thing as your state is not really true medical marijuana. However I do not see Georgia in the list that Michigan LARA created. Probably because a "low thc oil" "only" card is not really a medical marijuana card. Does your card look like this? https://www.michigan.gov/documents/lara/Ohio_Patient_ID_Cards_and_Out_of_State_Registration_624599_7.pdf Based on the available data, the following states are currently issuing medical marihuana cards or registration certifications to patients: • Alaska • Arizona • California • Colorado • Connecticut • Delaware • Florida • Hawaii • Illinois • Maine • Maryland • Massachusetts • Minnesota • Montana • Nevada • New Hampshire • New Jersey • New Mexico • New York • Ohio# • Oregon • Pennsylvania • Rhode Island • Vermont • Washington • Washington DC • West Virginia*

As Ethics go, you should probably not have any non-social worker relationship with any of your clients. this is probably in your social worker manual. Which means you could continue to be a caregiver, but get another case worker to take this case.

The profile picture changes are due to people using facebook to login. When they change facebook photo, it changes here too. Very annoying.

Letter to the editor Published 10:50 am EDT, Friday, October 5, 2018 To the editor, Cannabis should be legal and regulated for adults. Proposal 1 would regulate cannabis possession for adults away from kids, cars, and the public, and impose a 10 percent sin tax on cannabis sales plus 6 percent sales tax. It would forbid sales except through state licensed businesses. Licensed shop owners won't get rich. The IRS forbids normal business tax deductions so about 80 percent of profits will go straight into the public treasury. Proposal 1 protects landlords who don't want cannabis on their property, protects employers with workplace drug policies, keeps cannabis away from schools, and provides for drugged driving arrests for abusers. As an attorney I watched many lives ruined due to marijuana law enforcement, but cannabis itself poses no public safety threat. It is not a gateway drug, is not addictive, and is not harmful to humans. Cannabis is as popular as beer. Alcohol prohibition ended 85 years ago, and it is time to end cannabis prohibition. As a Republican and civil libertarian my view is that limited government, based on personal liberty and rule of law, should not try account for tastes. Laws that don't respect people breed people who don't respect laws. Vote "yes" on Proposal 1. Gregory Carl Schmid Saginaw https://www.michigansthumb.com/opinion/article/Attorney-on-pot-It-is-not-a-gateway-drug-13284185.php